Pharmaceutical

Alexion and Verge enter AI-powered drug discovery deal

Alexion has entered into a partnership with Verge Genomics to detect new drug targets for rare neurodegenerative and neuromuscular ailments.

Sep 11, 2023 - 20:00
Alexion and Verge enter AI-powered drug discovery deal
Alexion has entered into a partnership with Verge Genomics to detect new drug targets for rare neurodegenerative and neuromuscular ailments.
Read the original article

Tags:

Previous Article

Janssen seeks EMA authorisation for urothelial cancer treatment

Next Article

Moderna Forms Multi-Billion Dollar Strategic Partnership with Immatics

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: The ADC hot streak continues: J&J to buy cancer drug developer Ambrx Biopharma

STAT+: The ADC hot streak continues: J&J to buy cancer ...

Jan 8, 2024

STAT+: An innovative eye stem cell transplant could help restore vision in people with chemical injuries

STAT+: An innovative eye stem cell transplant could hel...

Aug 19, 2023

Top 20 biopharmas’ market cap up 4.3% in Q2 2024 as GLP-1 drug innovators hold top spots

Top 20 biopharmas’ market cap up 4.3% in Q2 2024 as GLP...

Aug 21, 2024